Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 38.40K | 45.80K | 44.20K | 41.10K | 34.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.10K | 1.67M | 62.00K | 50.90K | 69.60K |
| Operating Income | -44.10K | -1.67M | -62.00K | -50.90K | -69.60K |
| Income Before Tax | -44.10K | -1.67M | -62.00K | -50.90K | -69.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -44.10K | -1.67M | -62.00K | -50.90K | -69.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.10K | -1.67M | -62.00K | -50.90K | -69.60K |
| EBIT | -44.10K | -1.67M | -62.00K | -50.90K | -69.60K |
| EBITDA | -42.00K | -1.67M | -60.40K | -48.50K | -67.30K |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 151.74M | 149.57M | 146.74M | 146.74M | 143.98M |
| Average Diluted Shares Outstanding | 151.74M | 149.57M | 146.74M | 146.74M | 143.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |